Category: Patent Litigation
-

Supreme Court asked to clarify PTAB invalidation decisions have preclusive effect even if being appealed
The Federal Circuit apparently believes that its own affirmance of a PTAB invalidity finding has preclusive effect (even if the losing side could still petition for rehearing or certiorari), while a final PTAB decision does not.
-

No anti-antisuit injunction for Ericsson against Lenovo in Colombia while U.S. court is weighing antisuit motion
Lenovo, in an attempt to remind the court of the pendency of the TRO motion, argued Ericsson was making a renewed push for a Colombian anti-antisuit injunction. But Ericsson merely appealed in a case it lost on the technical merits.
-

Nokia-OPPO 5G patent dispute settled with license agreement after more than 2.5 years and OPPO leaving Germany
The Nokia v. OPPO 5G standard-essential patent dispute is history as the parties have agreed on a global cross-license agreement that puts an end to all litigation. OPPO paid a high price by exiting the German market in 2022, but has recently scored two strategic wins in China and Germany.
-

Federal Circuit reinstates Apple Watch ban because Apple can sell version without pulse oximetry: what’s next?
The Federal Circuit has reinstated the Apple Watch import and sales ban as of tomorrow, but apparently didn’t weigh the merits of the appeal and focused on the fact Apple has obtained clearance of a workaround version without pulse oximetry.
-

OPPO snatched victory from jaws of defeat in Federal Patent Court, may now get decisive leverage over Nokia
The Federal Patent Court of Germany initially deemed OPPO’s EP3445093 invalid, but after a 180-degree turnaround yesterday the patent poses a clear and present injunctive threat to Nokia’s German business. A German injunction could bring about a settlement at long last.
-

Philips and OPPO settle patent licensing dispute: UK court order
Philips and OPPO have settled their standard-essential patent dispute as a UK court order implies.
-

Apple asks court to allow continued sales of Apple Watch with pulse oximetry after securing clearance of version without
After securing customs clearance of an Apple Watch without pulse oximetry, Apple still asks the Federal Circuit to allow it to sell Apple Watches with that feature while its appeal is pending.
-

Apple free to import Apple Watch into U.S. market after removal of pulse oximetry feature: court filing
Masimo has just told the Federal Circuit that Apple’s modified Apple Watch, which comes without pulse oximetry, has been cleared by U.S. Customs and Border Protection as Apple removed the pulse oximetry feature altogether.
-

U.S. trade agency ITC incredibly portrays Apple as unrepentant infringer despite Masimo clearly abusing patents
The USITC incredibly accuses Apple of wanting to get away with intellectual property infringement while being completely insensitive to the serious issued raises by Masimo’s abusive patent filing tactics.
-

$5.22 per unit is aggregate 5G SEP royalty according to Lenovo’s deductions from UK High Court decisions
Lenovo points to the FRAND determinations from London in its own dispute with InterDigital and in Optis v. Apple, arguing that the total 5G stack value is $5.22/unit and Ericsson should therefore get only 23 cents.
